Determination of survival and hazard functions for pemphigus patients in Kerman, a southern province of Iran

International Journal of Dermatology

Volumn 45, Issue 6, 2006, Pages 668-671

  Shamsadini, Sadollah ^a   Fekri, Alireya R ^a   Esfandiarpoor, Iraj ^a   Saryazdi, Simin ^a   Rahnama, Zahra ^a   Zandi, Soodabeh ^a   Farajzadeh, Saeideh ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEALTH HAZARD; HOSPITAL ADMISSION; HUMAN; INFANT; IRAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT CARE; PATIENT IDENTIFICATION; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; CHILD; FEMALE; HOSPITAL RECORDS; HUMANS; IRAN; MALE; MIDDLE AGED; PEMPHIGUS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33745953598     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02614.x     Document Type: Article

References (28)

1. Arnold HL Jr, Odom RB, James WD, et al. Andrews' Diseases of the Skin: Clinical Dermatology, 8th edn. Philadelphia: W. B. Saunders Co., 1990; 534-543.
2. Ahmed AR, Yunis EJ, Khatri K, et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1990; 87: 7658.
3. Beutner HL, Chorzeiski TP, Hale WL, et al. Autoimmuity in concurrent myasthenia gravis and pemphigus ereythematosus. J Am Med Assoc 1968; 203: 845-849.
4. Beutner EH, Chorzelski TP. Studies on etiologic factors in pemphigus. J Cutan Pathol 1976; 3: 67-74.
5. Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34: 187-220.
6. Matsukawa Y, Sawada S, Hayama T, et al. Suicide in patients with systemic lupus erythematosus: A clinical analysis of seven suicidal patients. Lupus 1994; 3: 31-35.
7. Daly LE, Bourke GG, McGilvray J. Interpretation and Uses of Medical Statistics, 4th edn. 2000; 279-280.
8. Fletcher R. Basic Clinical Epidemiology. 1996; 211-217.
9. Armitag P, Berry G. Statistical Methods in Medical Research. London: Oxford, 1988.
10. Lee ET. Statistical Methods for Survival Data Analysis. Wiley, NY: John Wiley, 1992.
11. Lever WF, Schaumburg-Lever G. Histo Pathology. Philadelphia: J. B. Lippincott Co., 1990; 116-121.
12. Paterson AJ, Lamey PJ, Lewis MA, et al. Pemphigus vulagris precipitated by glibenclamide therapy. J Oral Pathol Med 1993; 22: 92-95.
13. Perez Bernal AM, Moreno J, Camacho F. Ten years' experience of the treatment of 34 cases of pemphigus. J Dermatol Treat 1992; 3: 73-75.
14. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet 1999; 354: 667-672.
15. Ahmed AR. Clinical features of pemphigus. Clin Dermatol 1983; 1: 13-21.
16. Alsaleh QA, Nanda A, Al-Baghli NM, et al. Pemphigus in Kuwait. Int J Dermatol 1999; 38: 351-356.
17. Lever WF. Pemphigus and pemphigoid: A review of the advances made since 1964. J Am Acad Dermatol 1979; 1: 2-31.
18. David JD. Fine vesicullobullus disease. In: Demis DJ, ed. Clinical Dermatology. Philadelphia: J. B. Lippincott Co., 1993; 2-10.
19. Micali G, Musumeci ML, Nasca MR. Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol 1998; 37: 197-200.
20. Ryan JG. Pemphigus: A 20-year survey of experience with 70 cases. Arch Dermatol 1971; 104: 14-20.
21. Fekri ARMD, Nikian MSP, Shamsadini SMD. Epidemiology of pemphigus and treatment outcome in Kerman. Natl Med J Kerman Univ Med Sci 1995; 1: 12-18.
22. Lever WF, Schaumburg-Lever G. Immunosuppressants and prednisone in pemphigus vulgaris: Therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol 1977; 113: 1236-1241.
23. Lever WF, Schaumburg-Lever G. Treatment of pemphigus vulgaris: Results obtained in 84 patients between 1961 and 1982. Arch Dermatol 1984; 120: 44-47.
24. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus: An update. Arch Dermatol 1996; 132: 203-212.
25. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall, 1984.
26. Lapidoth M, David M, Ben Amitai D, et al. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: Preliminary study. J Am Acad Dermatol 1994; 30: 752-757.
27. Wojna Rowska F, Eady RAJ, Burge SM. Bullous eruptions. In: Champion RH, Burton JL, Burns DA, et al., eds. Textbook of Dermatology, 6th edn. Oxford: Blackwell Science, 1998; 1817-1989.
28. Seniat Woldegiorgis MD, Robert A, Swerlick, MD. Pemphigus in the Southeastern United States. Med J 2001; 94: 694-698.